The Manitowoc Company, Inc.
NYSE:MTWAgricultural - Machinery
+$0.58 today
- Market cap
- $801.94M
- Beta
- 1.75
- P/E (TTM)
- 63.2
- EPS (TTM)
- $0.21
Volume 0.28M
Average 0.23M
MTW EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
The Manitowoc Company, Inc.NYSE: MTW
EBITDA · Q1 FY2026 · quarter ended Mar 2026
EBITDA dips below year-ago levels
Q1 FY2026 EBITDA of $14.5M fell 6.5% year over year, behind the +15.5% change in trailing-twelve-month EBITDA. Sequentially, it fell 62.5% from the prior quarter.
Context
- EBITDA amounted to 5.0% of revenue in FY2025, down 0.1 pp from a year earlier.
- EBITDA increased in 2 of the last 3 fiscal years.
What to watch
Whether EBITDA reaches the consensus estimate from 1 analysts of $148.39M (+31.2%) for the fiscal year ending Dec 2026, a step up from the +0.2% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- $14.5M-62.5% QoQ
- Last fiscal yearDec 2025
- $113.1M+0.2% YoY
- LTMMar 2026
- $112.5M+15.5% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -6.5% | +12.2% | +18.6 pp |
| 1 year | +0.2% | +31.2% | +31.0 pp |
| 3-year CAGR | — | +14.4% | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- 113.1M USD
- Year-over-year change
- +0.2%
- 4-year CAGR
- +5.0%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 113.1M | +0.2% |
| FY2024 | 2024-12-31 | 112.9M | -18.9% |
| FY2023 | 2023-12-31 | 139.2M | +659.0% |
| FY2022 | 2022-12-31 | (24.9M) | -126.8% |
| FY2021 | 2021-12-31 | 92.9M | — |
EBITDA vs competitors
How MTW compares with its peers on the latest reported figures
- MTW's LTM Mar 2026 EBITDA of $112.5M is the 3rd highest of the 10 companies compared; the peer median is $35.7M.
- Its year-over-year change of +15.5% is the 4th highest of 10, against a peer median of -12.7%.
- EBITDA amounts to 5.0% of revenue for MTW, versus a peer median of 6.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $227.82M | +21.4% | +2.0% | 61.2% | |
| LTM Mar 2026 | $197.9M | +904.6% | +6.2% | 12.8% | |
| LTM Mar 2026 | $112.5M | +15.5% | — | 5.0% | |
| LTM Mar 2026 | $105.4M | -12.7% | +11.8% | 6.5% | |
SBCSBC Medical Group Holdings Incorporated | LTM Mar 2026 | $72.43M | -10.7% | +42.0% | 42.8% |
| LTM Mar 2026 | $35.7M | -25.6% | -15.4% | 9.6% | |
| LTM Mar 2026 | $22.19M | -70.9% | -12.1% | 4.0% | |
| LTM Mar 2026 | -$3.18M | +92.7% | +19.2% | 0.2% | |
| LTM Mar 2026 | -$39.84M | -15.9% | -23.6% | 6.0% | |
| LTM Mar 2026 | -$174.35M | -15.4% | — | 5.5% | |
| Peer median (excluding MTW) | $35.7M | -12.7% | +4.1% | 6.5% | |
Competitors are the stored peer set for MTW. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.72B | 2.03B | 2.23B | 2.18B | 2.24B |
| Cost of Revenue | 1.41B | 1.67B | 1.8B | 1.8B | 1.84B |
| Gross Profit | 307.2M | 364.5M | 425.2M | 375M | 404.7M |
| Gross Margin | 17.9% | 17.9% | 19.1% | 17.2% | 18.1% |
| Research & Development | 0 | 0 | 35.3M | 0 | 0 |
| Selling, General & Admin | 258.5M | 281M | 334.3M | 318.6M | 342.9M |
| Operating Expenses | 260.7M | 457.5M | 332.8M | 323.2M | 346M |
| Depreciation & Amortization | 46.9M | 63.7M | 59.8M | 62.9M | 63M |
| EBITDA | 92.9M | (24.9M) | 139.2M | 112.9M | 113.1M |
| EBITDA Margin | 5.4% | -1.2% | 6.2% | 5.2% | 5.0% |
| Operating Income | 46.5M | (93M) | 92.4M | 51.8M | 58.7M |
| Operating Margin | 2.7% | -4.6% | 4.1% | 2.4% | 2.6% |
| Interest Income | 0 | 0 | 0 | 0 | 800K |
| Interest Expense | 28.9M | 31.6M | 35.2M | 39.7M | 37.7M |
| Other Income / Expenses | (29.4M) | (27.2M) | (48.2M) | (40.1M) | (46.3M) |
| Income Before Tax | 17.1M | (120.2M) | 44.2M | 11.7M | 12.4M |
| Pre-Tax Margin | 1.0% | -5.9% | 2.0% | 0.5% | 0.6% |
| Income Tax Expense | 6.1M | 3.4M | 5M | (44.1M) | 5.2M |
| Net Income | 11M | (123.6M) | 39.2M | 55.8M | 7.2M |
| Net Margin | 0.6% | -6.1% | 1.8% | 2.6% | 0.3% |
| EPS (Basic) | 0.32 | (3.51) | 1.12 | 1.58 | 0.20 |
| EPS (Diluted) | 0.31 | (3.51) | 1.09 | 1.56 | 0.20 |
| Weighted Avg Shares | 34.9M | 35.18M | 35.09M | 35.22M | 35.42M |
| Weighted Avg Shares (Diluted) | 35.45M | 35.18M | 35.96M | 35.71M | 36.09M |
The Manitowoc Company, Inc.
NYSE:MTW
Intrinsic Alpha fair value
Locked
Current Price
$22.21
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.